Status:

ACTIVE_NOT_RECRUITING

Performance of PEAR 2.0 Software in Prescribing Biotherapy in Patients With Rheumatoid Arthritis

Lead Sponsor:

CEN Biotech

Collaborating Sponsors:

MYEXPRESION

Conditions:

Polyarthritis; Rheumatoid

Eligibility:

All Genders

18+ years

Brief Summary

The management of rheumatoid arthritis is based on the prescription of disease-modifying anti-rheumatic drugs (DMARDs) to induce clinical and biological remission. If the first line of treatment (meth...

Detailed Description

This study plans to include 234 patients who, like you, suffer from rheumatoid arthritis, and who will initiate biotherapy in one of the hospital departments taking part in this research. The main obj...

Eligibility Criteria

Inclusion

  • Male or female 18 years or older ;
  • With severe rheumatoid arthritis (DAS 28 ≥ 5.1) or moderate rheumatoid arthritis (DAS 28 3.2 ≥ and \<5.1);
  • For whom one of the 6 biotherapies Etanercept, Adalimumab, Infliximab, Rituximab, Tocilizumab, Abatacept, or respective biosimilars, is planned, and accepting treatment after having been duly informed of the risks and benefits of the biotherapy;
  • Agreeing to the collection of an additional volume of blood for transcriptomic analysis;
  • Having given their free, informed and express written consent;
  • Affiliated with a French social security scheme.

Exclusion

  • Biotherapies not analyzed by RITI (Certolizumab, Golimumab, Anakinra, Sarilumab);
  • Combination of biotherapies or combination with a tsDMARD);
  • Patients under judicial protection (curatorship, guardianship, safeguard of justice) or patients with psychotic disorders unable to complete quality of life and assessment questionnaires;
  • Already included in an interventional study or in the exclusion period of an interventional study.

Key Trial Info

Start Date :

May 5 2023

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

March 31 2026

Estimated Enrollment :

239 Patients enrolled

Trial Details

Trial ID

NCT06186375

Start Date

May 5 2023

End Date

March 31 2026

Last Update

August 6 2025

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

University Hospital of DIJON

Dijon, France, 21000

2

Hôpital Roger Salengro University Hospital of Lille

Lille, France, 59037

3

Hospital of Orleans

Orléans, France, 45100

4

University Hospital of Saint-Etienne

Saint-Priest-en-Jarez, France, 42270